Clinical trial
Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets
NCT00913549 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets
- Lead sponsor
- Sandoz
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 31, 1989
- Completion date
- January 31, 1990
- Enrollment
- 36 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
allergy